Patent ID: 11884734
Assignee: CELLDEX THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A monoclonal antibody or antigen-binding fragment thereof that binds to human MET, wherein the antibody or antigen-binding fragment thereof comprises:
a. a light chain variable region (“VL”) comprising:
i. a VL CDR1 comprising the amino acid sequence of SEQ ID NO: 13;
ii. a VL CDR2 comprising the amino acid sequence of SEQ ID NO: 14; and
iii. a VL CDR3 comprising the amino acid sequence of SEQ ID NO: 15; and

b. a heavy chain variable region (“VH”) comprising:
i. a VH CDR1 comprising the amino acid sequence of SEQ ID NO: 16;
ii. a VH CDR2 comprising the amino acid sequence of SEQ ID NO: 17; and
iii. a VH CDR3 comprising the amino acid sequence of SEQ ID NO: 18.